Reviews
Average rating: 5/5
Physician ( 1 )
-
5
-
4
-
3
-
2
-
1
Average rating: 5.00/5
Total Reviews: 1
-
5
-
4
-
3
-
2
-
1
Tenecteplase (TNKase) is a thrombolytic now FDA-approved for acute ischemic stroke and offers the advantage of a single IV bolus dose instead of an infusion. I am careful to confirm patients meet full eligibility criteria and are within the treatment time window, as the main risk remains intracranial hemorrhage. When used appropriately, it provides outcomes comparable to alteplase with simpler administration.
0